NAGE

Niagen Bioscience

82 hedge funds and large institutions have $49.9M invested in Niagen Bioscience in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 8382 (-1)

34% less capital invested

Capital invested by funds: $75.8M → $49.9M (-$25.9M)

40% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 30

Holders
82
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$478K
Puts
$255K
Net Calls
Net Calls Change

Top Sellers

1 -$1.55M
2 -$1.4M
3 -$1M
4
Millennium Management
Millennium Management
New York
-$845K
5
Goldman Sachs
Goldman Sachs
New York
-$186K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$49K
52
$44K
53
$44K
54
$42K
55
$39K
56
$39K
57
$37K
58
$36K
59
$35K
60
$31K
61
$29K
62
$28K
63
$27.7K
64
$26K
65
$23K
66
$19K
67
$19K
68
$17K
69
$16.7K
70
$14K
71
$13K
72
$12K
73
$11K
74
$10.9K
75
$10K